Advertisement
Screener

Clovis Oncology, Inc. Operating Cash Flow

Clovis Oncology, Inc. Operating Cash Flow

Clovis Oncology, Inc. reported Operating Cash Flow of -$134.23 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-09

  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$40.61M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$35.13M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$58.49M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$41.34M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$196.06M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$252.73M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$323.62M.
  • Clovis Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$366.00M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 35 monthNet Cash Provided by (Used in) Operating Activities 38 monthNet Cash Provided by (Used in) Operating Activities 41 monthNet Cash Provided by (Used in) Operating Activities 44 monthNet Cash Provided by (Used in) Operating Activities 47 month
2022-09-30-$40.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$75.74M
derived: sum of 2 quarters · filed 2022-11-09
-$134.23M
10-Q · filed 2022-11-09
-$175.57M
derived: sum of 4 quarters · filed 2022-11-09
2022-06-30-$35.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$93.62M
10-Q · filed 2022-08-08
-$134.97M
derived: sum of 3 quarters · filed 2022-08-08
-$181.03M
derived: sum of 4 quarters · filed 2022-11-09
2022-03-31-$58.49M
10-Q · filed 2022-05-05
-$99.84M
derived: sum of 2 quarters · filed 2022-05-05
-$145.91M
derived: sum of 3 quarters · filed 2022-11-09
-$192.66M
derived: sum of 4 quarters · filed 2022-11-09
2021-12-31-$41.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$87.41M
derived: sum of 2 quarters · filed 2022-11-09
-$134.17M
derived: sum of 3 quarters · filed 2022-11-09
-$196.06M
10-K · filed 2022-02-24
2021-09-30-$46.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$92.82M
derived: sum of 2 quarters · filed 2022-11-09
-$154.71M
10-Q · filed 2022-11-09
-$210.77M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$46.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$108.64M
10-Q · filed 2022-08-08
-$164.70M
derived: sum of 3 quarters · filed 2022-08-08
-$219.02M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31-$61.89M
10-Q · filed 2022-05-05
-$117.94M
derived: sum of 2 quarters · filed 2022-05-05
-$172.27M
derived: sum of 3 quarters · filed 2022-05-05
-$232.12M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$56.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$110.38M
derived: sum of 2 quarters · filed 2022-02-24
-$170.23M
derived: sum of 3 quarters · filed 2022-02-24
-$252.73M
10-K · filed 2022-02-24
2020-09-30-$54.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
-$114.18M
derived: sum of 2 quarters · filed 2021-11-03
-$196.68M
10-Q · filed 2021-11-03
-$266.82M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$59.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
-$142.35M
10-Q · filed 2021-08-04
-$212.50M
derived: sum of 3 quarters · filed 2022-02-24
-$269.48M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$82.49M
10-Q · filed 2021-05-05
-$152.64M
derived: sum of 2 quarters · filed 2022-02-24
-$209.62M
derived: sum of 3 quarters · filed 2022-02-24
-$307.66M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$70.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$127.13M
derived: sum of 2 quarters · filed 2022-02-24
-$225.16M
derived: sum of 3 quarters · filed 2022-02-24
-$323.62M
10-K · filed 2022-02-24
2019-09-30-$56.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$155.02M
derived: sum of 2 quarters · filed 2020-11-05
-$253.47M
10-Q · filed 2020-11-05
-$336.19M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$98.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$196.49M
10-Q · filed 2020-08-07
-$279.21M
derived: sum of 3 quarters · filed 2021-02-25
-$351.64M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$98.45M
10-Q · filed 2020-05-06
-$181.18M
derived: sum of 2 quarters · filed 2021-02-25
-$253.60M
derived: sum of 3 quarters · filed 2021-02-25
-$363.81M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$82.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$155.15M
derived: sum of 2 quarters · filed 2021-02-25
-$265.36M
derived: sum of 3 quarters · filed 2021-02-25
-$366.00M
10-K · filed 2021-02-25
2018-09-30-$72.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$182.63M
derived: sum of 2 quarters · filed 2019-11-07
-$283.27M
10-Q · filed 2019-11-07
-$348.85M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$110.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$210.84M
10-Q · filed 2019-08-02
-$276.42M
derived: sum of 3 quarters · filed 2020-02-26
-$322.21M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$100.64M
10-Q · filed 2019-05-07
-$166.21M
derived: sum of 2 quarters · filed 2020-02-26
-$212.00M
derived: sum of 3 quarters · filed 2020-02-26
-$281.10M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$65.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$111.36M
derived: sum of 2 quarters · filed 2020-02-26
-$180.47M
derived: sum of 3 quarters · filed 2020-02-26
-$260.90M
10-K · filed 2020-02-26
2017-09-30-$45.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$114.89M
derived: sum of 2 quarters · filed 2018-11-01
-$195.33M
10-Q · filed 2018-11-01
-$250.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$69.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$149.54M
10-Q · filed 2018-08-02
-$204.22M
derived: sum of 3 quarters · filed 2019-02-28
-$264.55M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$80.44M
10-Q · filed 2018-05-09
-$135.11M
derived: sum of 2 quarters · filed 2019-02-28
-$195.45M
derived: sum of 3 quarters · filed 2019-02-28
2016-12-31-$54.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$115.01M
derived: sum of 2 quarters · filed 2019-02-28
-$266.68M
10-K · filed 2019-02-28
2016-09-30-$60.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$212.00M
10-Q · filed 2017-11-02
2016-06-30-$151.67M
10-Q · filed 2017-08-03
2015-12-31-$253.07M
10-K · filed 2018-02-27
2013-03-31-$14.48M
10-Q · filed 2013-05-08
-$33.12M
derived: sum of 2 quarters · filed 2013-05-08
-$47.42M
derived: sum of 3 quarters · filed 2013-05-08
-$61.31M
derived: sum of 4 quarters · filed 2013-05-08
-$171.66M
10-Q · filed 2013-05-08
2012-12-31-$18.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$32.94M
derived: sum of 2 quarters · filed 2013-03-14
-$46.83M
derived: sum of 3 quarters · filed 2013-03-14
-$65.38M
10-K · filed 2013-03-14
-$157.18M
10-K · filed 2013-03-14
2012-09-30-$14.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
-$28.20M
derived: sum of 2 quarters · filed 2012-11-14
-$46.75M
10-Q · filed 2012-11-14
-$59.41M
derived: sum of 4 quarters · filed 2013-05-08
-$138.54M
10-Q · filed 2012-11-14
2012-06-30-$13.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
-$32.45M
10-Q · filed 2012-08-10
-$45.11M
derived: sum of 3 quarters · filed 2013-05-08
-$54.36M
derived: sum of 4 quarters · filed 2013-05-08
-$124.24M
10-Q · filed 2012-08-10
2012-03-31-$18.55M
10-Q · filed 2013-05-08
-$31.22M
derived: sum of 2 quarters · filed 2013-05-08
-$40.47M
derived: sum of 3 quarters · filed 2013-05-08
-$50.19M
derived: sum of 4 quarters · filed 2013-05-08
-$110.35M
10-Q · filed 2012-05-11
2011-12-31-$12.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$21.91M
derived: sum of 2 quarters · filed 2013-03-14
-$31.64M
derived: sum of 3 quarters · filed 2013-03-14
-$39.83M
10-K · filed 2013-03-14
2011-09-30-$9.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
-$18.98M
derived: sum of 2 quarters · filed 2012-11-14
-$27.16M
10-Q · filed 2012-11-14
2011-06-30-$9.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
-$17.91M
10-Q · filed 2012-08-10
2011-03-31-$8.19M
10-Q · filed 2012-05-11
2010-12-31-$34.01M
10-K · filed 2013-03-14